BDBM435044 (2S)-2-[(5-fluorobenzofuran-2-yl)sulfonylamino]-N- [[1-isopropyl-4-methyl-2,6-dioxo-3-[4- (trifluoromethyl)phenyl]pyrimidin-5- yl]methyl]propanamide::US10584116, Example 24

SMILES CC(C)n1c(=O)c(CNC(=O)[C@H](C)NS(=O)(=O)c2cc3cc(F)ccc3o2)cn(-c2ccc(cc2)C(F)(F)F)c1=O

InChI Key InChIKey=GBLOYKHDXVMKKU-HNNXBMFYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 435044   

TargetTransient receptor potential cation channel subfamily A member 1(Homo sapiens (Human))
Ea Pharma

US Patent
LigandPNGBDBM435044((2S)-2-[(5-fluorobenzofuran-2-yl)sulfonylamino]-N-...)
Affinity DataIC50:  42nMAssay Description:Human TRPA1 Expression PlasmidUsing cDNA encoding human TRPA1 (GenBank accession No. NM_007332) (manufactured by Kazusa DNA Research Institute, item ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent